BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 18657245)

  • 1. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
    Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in Saudi Arabia.
    Al-Nozha M; Al-Khadra A; Arafah MR; Al-Maatouq MA; Khalil MZ; Khan NB; Al-Mazrou YY; Al-Marzouki K; Al-Harthi SS; Abdullah M; Al-Shahid MS; Al-Mobeireek A; Nouh MS
    Saudi Med J; 2005 Dec; 26(12):1918-25. PubMed ID: 16380773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
    Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
    Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of metabolic syndrome in patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Benabarre A; Sierra P; Perez J; Rodriguez A; Livianos L; Torres P; Bobes J
    J Affect Disord; 2008 Feb; 106(1-2):197-201. PubMed ID: 17631970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
    Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
    Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of valproate in metabolic disturbances in bipolar disorder patients.
    Chang HH; Yang YK; Gean PW; Huang HC; Chen PS; Lu RB
    J Affect Disord; 2010 Aug; 124(3):319-23. PubMed ID: 20060174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan.
    Chang HH; Chou CH; Chen PS; Gean PW; Huang HC; Lin CY; Yang YK; Lu RB
    J Affect Disord; 2009 Sep; 117(1-2):124-9. PubMed ID: 19193445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
    Wasir JS; Misra A; Vikram NK; Pandey RM; Gupta R
    J Assoc Physicians India; 2008 Mar; 56():158-64. PubMed ID: 18697631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project.
    Gil K; Radziłłowicz P; Zdrojewski T; Pakalska-Korcala A; Chwojnicki K; Piwoński J; Ignaszewska-Wyrzykowska A; Załuga L; Mielczarek M; Landowski J; Wyrzykowski B
    Kardiol Pol; 2006 May; 64(5):464-9. PubMed ID: 16752328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
    Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
    Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sociodemographic risk factors of metabolic syndrome in middle-aged women: results from a population-based study of Swedish women, The Women's Health in the Lund Area (WHILA) Study.
    Qader SS; Shakir YA; Nyberg P; Samsioe G
    Climacteric; 2008; 11(6):475-82. PubMed ID: 18991074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals.
    Ishizaka N; Ishizaka Y; Toda E; Hashimoto H; Nagai R; Yamakado M
    Hypertens Res; 2005 Jan; 28(1):27-34. PubMed ID: 15969252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.